ACE2 elevation in severe COVID-19

R Reindl-Schwaighofer, S Hödlmoser… - American journal of …, 2021 - atsjournals.org
Methods We measured enzymatically active plasma ACE2 concentration (subsequently
referred to as “ACE2”) and key RAS metabolites in 532 blood samples obtained from 126 …

Human influenza virus infections

C Peteranderl, S Herold… - Seminars in respiratory …, 2016 - thieme-connect.com
Seasonal and pandemic influenza are the two faces of respiratory infections caused by
influenza viruses in humans. As seasonal influenza occurs on an annual basis, the …

ACE2 in the era of SARS-CoV-2: controversies and novel perspectives

F Saponaro, G Rutigliano, S Sestito… - Frontiers in Molecular …, 2020 - frontiersin.org
Angiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract
several pathophysiological actions of ACE. ACE2 exerts antihypertensive and …

On facing the SARS-CoV-2 (COVID-19) with combination of nanomaterials and medicine: possible strategies and first challenges

VS Sivasankarapillai, AM Pillai, A Rahdar, AP Sobha… - Nanomaterials, 2020 - mdpi.com
Global health is facing the most dangerous situation regarding the novel severe acute
respiratory syndrome called coronavirus 2 (SARS-CoV-2), which is widely known as the …

Recombinant human ACE2: acing out angiotensin II in ARDS therapy

H Zhang, A Baker - Critical Care, 2017 - Springer
Acute respiratory distress syndrome (ARDS) is a devastating inflammatory lung disorder that
is frequently associated with multiple organ dysfunction leading to high mortality. The …

[PDF][PDF] COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic …

D Atri, HK Siddiqi, J Lang, V Nauffal… - … Basic Transl Sci, 2020 - portailvasculaire.fr
Summary The coronavirus disease-2019 (COVID-19), a contagious disease caused by
severe acute respiratory syndrome coronavirus-2 (SARS-CoV2), has reached pandemic …

The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions

T Behl, I Kaur, S Bungau, A Kumar, MS Uddin, C Kumar… - Life Sciences, 2020 - Elsevier
The novel corona virus disease has shaken the entire world with its deadly effects and rapid
transmission rates, posing a significant challenge to the healthcare authorities to develop …

Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus

H Gu, Z Xie, T Li, S Zhang, C Lai, P Zhu, K Wang… - Scientific reports, 2016 - nature.com
Respiratory syncytial virus (RSV) infection is a major cause of severe lower respiratory
illness in infants and young children, but the underlying mechanisms responsible for viral …

A current review of COVID-19 for the cardiovascular specialist

JP Lang, X Wang, FA Moura, HK Siddiqi… - American heart …, 2020 - Elsevier
Abstract Although coronavirus disease 2019 (COVID-19) predominantly disrupts the
respiratory system, there is accumulating experience that the disease, particularly in its more …

Diabetes and metabolic syndrome as risk factors for COVID-19

M Marhl, V Grubelnik, M Magdič, R Markovič - Diabetes & Metabolic …, 2020 - Elsevier
Background and aims Clinical evidence exists that patients with diabetes are at higher risk
for Coronavirus disease 2019 (COVID-19). We investigated the physiological origins of this …